<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2450">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05129267</url>
  </required_header>
  <id_info>
    <org_study_id>PER 3- 3- 2</org_study_id>
    <nct_id>NCT05129267</nct_id>
  </id_info>
  <brief_title>Evaluation of iPRF With Vitamin C in StageII Grade A Periodontitis</brief_title>
  <official_title>Evaluation of Injectable PRF With Vitamin C as an Adjunct to Non-surgical Therapy in the Treatment of Stage II Grade A Periodontitis. A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing the effect of using vitamin C with injectable PRF as a locally delivered adjunct to&#xD;
      scaling and root planing versus scaling and root planing with local delivery of injectable&#xD;
      PRF and scaling and root planing alone on the clinical parameters in Stage II Grade A&#xD;
      Periodontitis patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The conventional approach:&#xD;
&#xD;
      Group 1: Scaling and root planing alone using Gracey curettes and ultrasonic scalers.&#xD;
&#xD;
      Group 2: Scaling and root planing using Gracey curettes and ultrasonic scalers with local&#xD;
      delivery of injectable PRF using an insulin syringe with the blunt needle inserted into the&#xD;
      bottom of the periodontal pocket through a template to hold the locally delivered injectable&#xD;
      PRF.&#xD;
&#xD;
      The intervention approach:&#xD;
&#xD;
      Scaling and root planing using Gracey curettes and ultrasonic scalers with local delivery of&#xD;
      vitamin C (250 μM) and injectable PRF, using an insulin syringe with the blunt needle&#xD;
      inserted into the bottom of the periodontal pocket through a template to hold the locally&#xD;
      delivered vitamin C and injectable PRF for a longer time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 3, 2021</start_date>
  <completion_date type="Anticipated">June 2, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding on Probing (BOP)</measure>
    <time_frame>3 months</time_frame>
    <description>Gentle probing of the orifice of the gingival crevice. The periodontal probe will be inserted 1 to 2 mm into the gingival sulcus starting at one interproximal area and moving to the other. If bleeding occurs within 10 seconds a positive finding is recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Probing Depth (PD)</measure>
    <time_frame>6 months</time_frame>
    <description>Measured from the gingival margin to the bottom of the gingival sulcus. Each tooth will be probed with a light force not exceeding 25 grams at 6 sites.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Attachment Level (CAL)</measure>
    <time_frame>6 months</time_frame>
    <description>Measured from the CEJ to the bottom of the gingival sulcus, or will be calculated as the algebraic sum of gingival recession and PD measurements for each site. Each tooth will be probed with a light force not exceeding 25 grams at six points: (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, and disto-lingual).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival Marginal Level (GML)</measure>
    <time_frame>6 months</time_frame>
    <description>Measured from the free gingiva to CEJ.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Index (PI)</measure>
    <time_frame>6 months</time_frame>
    <description>Teeth in each quadrant will be dried with a blast of air, and presence of visible dental plaque will be recorded with scores 0, 1, 2, 3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoral Radiographs</measure>
    <time_frame>6 months</time_frame>
    <description>A customized X-ray positioning stent will be fabricated to allow easy and accurate radiographing and retain the plastic film holder in the paralleling radiographic technique.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-Operative Pain</measure>
    <time_frame>48 hours</time_frame>
    <description>Visual Analogue Scale (VAS) with numbers from 0 to 10 ('no pain' to 'worst pain imaginable') measured daily for the first 2 days postoperatively.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scaling and Root Debridement + iPRF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scaling and Root Debridement + iPRF +Vitamin C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Scaling and Root Debridement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group B</intervention_name>
    <description>Scaling and Root debridement + iPRF</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group C</intervention_name>
    <description>Scaling and Root debridement + iPRF together with vitamin C</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with healthy systemic condition.&#xD;
&#xD;
          2. Adult patients ˃ 18 years old.&#xD;
&#xD;
          3. Patients with Stage II Grade A periodontitis.&#xD;
&#xD;
          4. Patients accept 6-months follow-up period (cooperative patients).&#xD;
&#xD;
          5. Patients provide an informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of prosthetic crowns.&#xD;
&#xD;
          2. Extensive restorations.&#xD;
&#xD;
          3. Periodontal therapy within the last 12 months.&#xD;
&#xD;
          4. Having surgical therapy or undergoing orthodontic treatment.&#xD;
&#xD;
          5. Ongoing drug therapy that might have an impact on the clinical signs and symptoms of&#xD;
             periodontitis.&#xD;
&#xD;
          6. The use of antibiotics or anti-inflammatory drugs 1 month prior to the procedure and&#xD;
             till the end of 6 months of follow-up.&#xD;
&#xD;
          7. Smokers.&#xD;
&#xD;
          8. Pregnant females.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed Ab Sherif</last_name>
    <phone>01118222827</phone>
    <email>mohamedsherif@dentistry.cu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Oral and Dental Medecine-CU</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Ab Sherif, Master</last_name>
      <phone>01118222827</phone>
      <email>mohamedsherif@dentistry.cu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 10, 2021</study_first_submitted>
  <study_first_submitted_qc>November 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohamed Abdulhakim Mohamed Sherif</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

